Prozomix Awarded FP7 R&D Grant
Prozomix is pleased to announce that as part of a 17 strong academic / commercial EU consortium, it has been awarded a highly competitive research grant under the FP7-KBBE Programme. The €7.8 M "KYROBIO" Project (Grant No. 289646) aims to "discover, develop and demonstrate biocatalysts for use in the industrial synthesis of chiral chemicals"
Prozomix is pleased to announce that as part of a 17 strong academic / commercial EU consortium, it has been awarded a highly competitive research grant under the FP7-KBBE Programme. The €7.8 M “KYROBIO” Project (Grant No. 289646) aims to “discover, develop and demonstrate biocatalysts for use in the industrial synthesis of chiral chemicals”. The specific role of Prozomix is to use it’s advanced enzyme capabilities in the discovery, development and commercialisation of novel nitrile hydratase biocatalysts. The work to be performed over a 4-year period will see the company apply it’s proprietary GRASP™ technology to this challenging class of enzyme, resulting in a large, novel and diverse panel of nitrile hydratases being developed, and offered commercially. Members of this new panel will become commercially available from mid / late 2012, including as part of the Prozomix Biocatalysis Enzyme Toolkit.
The other members of the KYROBIO consortium are BICT, Ingenza, CLEA Technologies, BioInfoBank Institute, VTU Technology, ACIB, University of Graz, X-Zyme, evocatal, Bio-prodict, University of Manchester, CIKTN, C-Tech Innovation, University of Groningan, University of Stuttgart, and the Technical University of Denmark.
Please contact info@prozomix.com for further information.